PRESS RELEASES More events are coming soon. Keyword Search Year: 202120202019201820172016201520142013 06/04/21 Summary ToggleTRACON Pharmaceuticals Presents Data from a Phase 1 Study of Uliledlimab (TJ004309) and Tecentriq® (Atezolizumab) at the American Society of Clinical Oncology Virtual Annual Meeting Printer Friendly PDF Version 06/01/21 Summary ToggleTRACON Pharmaceuticals Announces Results of Independent Data Monitoring Committee Review of Safety Data from ENVASARC Pivotal Trial Printer Friendly PDF Version 05/25/21 Summary ToggleTRACON Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference Printer Friendly PDF Version 05/20/21 Summary ToggleTRACON Pharmaceuticals Announces Poster Presentations at the 2021 ASCO Virtual Annual Meeting Printer Friendly PDF Version 05/05/21 Summary ToggleTRACON Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update Printer Friendly PDF Version 05/03/21 Summary ToggleTRACON Pharmaceuticals Announces Appointment of Dongliang Zhuang, Ph.D. as Vice President of Statistics and Biometrics Printer Friendly PDF Version 04/28/21 Summary ToggleTRACON to Report First Quarter 2021 Financial Results and Company Highlights on May 5, 2021 Printer Friendly PDF Version 03/23/21 Summary ToggleTRACON Pharmaceuticals Announces Poster Presentation at the 2021 AACR Virtual Annual Meeting Printer Friendly PDF Version 03/09/21 Summary ToggleTRACON Pharmaceuticals to Present at the Oppenheimer 31st Annual Healthcare Conference Printer Friendly PDF Version 03/08/21 Summary ToggleTRACON Pharmaceuticals Announces Appointment of Lisa Johnson-Pratt, M.D., to its Board of Directors Printer Friendly PDF Version Pagination Current page 1 Page 2 Page 3 Page 4 … Next page Next Last page Last
